(Q50953894)
Statements
Epalrestat, an aldose reductase inhibitor, improves an impaired generation of oxygen-derived free radicals by neutrophils from poorly controlled NIDDM patients. (English)
1 reference
Sato N
1 reference
Kashima K
1 reference
Uehara Y
1 reference
Ohtani K
1 reference
Shimizu H
1 reference
Mori M
1 reference
1 June 1997
1 reference
20
1 reference
6
1 reference
995-998
1 reference
Identifiers
1 reference